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Introduction 
Currently, colorectal cancer (CRC) is the second cause of death in EU[1]. In EU, the Czech Republic and 
Slovakia showed the highest rates. By contrast, Greece presented the lowest rates across Europe[2, 3]. This 
incidence is postulated to reflect risk factors associated to socioeconomic status, including poor dietary 
habits and obesity. However, emerging evidence also implicates gut microbiota as an important effector in 
the relationship among diet, human health and cancer[4]. 
 
Methods 
A novel integrative strategy to deeper understanding of CRC is vital. To accomplish this, a real-life scenario 
is needed. In this context, colon organoids/tumoroids will be established. Afterwards, an apple will be 
digested/fermented in vitro using a batch culture colonic model inoculated with feces from lean/obese 
healthy donors. In the end, such polyphenol metabolites will be tested in colon organoids/tumoroids and 
the mechanisms of action will be revealed by metabolomics and organoids assays. 
 
Results 
In summary, the results from TRIANGLE through the integration of polyphenols (diet), gut microbiota and 
colon organoids (host), will be highly multidisciplinary, and will undoubtedly set the stage towards the 
identification of mechanisms contributing to CRC understanding and will ultimately pave the way to 
phytochemical treatment and prevention. First, it is still unknown how apple phytochemicals are affected 
by lean and obese microbiotas, and it must be understood in order to comprehend chemopreventive 
efficacy of polyphenols and to be able to give nutritional recommendations related to functional-group 
class therein. Secondly, tumor organoids (tumoroids) and organoids can bridge the gap between human 2D 
cancer cell lines and animal-based models. Lastly, metabolomics analysis and 3D cell assays of colon 
organoids/tumoroids will provide valuable new insights into the mechanisms by which nutrient-gene 
interaction influences colon stem cell niche and CRC, and will open up new possibilities for CRC 
understanding and prevention. 
 
Conclusions 
TRIANGLE will provide novel insights towards CRC prevention by (1) using a new in vitro model based on 
colon organoids, (2) considering both gut microbiota composition and microbial metabolites, and (3) 
applying novel techniques. By implementing this, colon organoids will clearly mimic human real-life 
scenario. Secondly, the manner how polyphenols are affected by microbiotas will reveal the type and 
quantity of polyphenol metabolites, which could be correlated to the chemoprevention of CRC. 
 
Novel Aspect 
Metabolomics will provide a holistic signature in organoids and, together with organoid assay data can 
generate new hypotheses regarding underlying the mechanisms by which polyphenol-gene interaction 
influences CRC. 
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Introduction 
Biotransformation products of tryptophan are gaining an increasing multi-faceted interest as nutritional 
supplements to cope with environmental and lifestyle related stressors. Their identification and 
measurement in nutritional and biological matrices mandates for flexible, yet accurate and precise 
analytical methods based on mass spectrometry and adapted to studies with stable isotopic labels. 
Fragmentation studies are necessary to fulfil this aim. 
 
Methods 
An API3000 LTQ LC-MS system is used for extensive tandem MS fragmentation studies on 3 tryptophan 
amino-acids, 4 tryptamines and 3 N-acetyl-tryptamines. A stable-isotope analogue of melatonin is custom 
synthesized. LC separation and quantification parameters are optimized for the detection by MRM of 8 
analytes and 3 internal standards in four different biological and food matrices. 
 
Results 
Spectroscopic studies highlight key fragmentation pathways for the identification and measurement of 8 
target analytes. The study of the fragmentation pattern [1] allowed designing and synthesizing[2] an under-
considered isotope-labelled form of melatonin [3], to improve quantification by ID-MS-MS, with respect to 
previously employed isotopologues. Furthermore, the discrimination of the critical pair of isobaric 
melatonin and isomeric tryptophan ethyl ester, that also yield very similar fragmentation, could be 
accomplished with a scan function that addresses a triplet of consecutive fragments, only a pair of which 
are specific for each compound. With this method, the levels of melatonin and of its metabolic pathway are 
measured in human fluids from several unique conditions, as well as from nutraceutical and 
pharmaceutical formulations and food matrices. 
 
Conclusions 
Accurate fragmentation studies of biological indole compounds supply information to design a new internal 
standard for isotope dilution measurement of melatonin, and identification and quantification methods 
suitable for the measurement of the indolome in different natural matrices of interest for biological and 
technological applications. 
 
Novel Aspect 
An innovative internal standard to measure melatonin by ID-MS-MS and a method to discriminate isomers 
and isobars of melatonin are proposed. 
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